Rapamycin Prevents Expansion of Costimulation Blockade-resistant CD8+ Alloreactive Memory Cells following Depletional Induction in Renal Transplant Recipients.

dc.contributor.author

Li, Shu

dc.contributor.author

Gao, Qimeng

dc.contributor.author

Xu, He

dc.contributor.author

Kirk, Allan D

dc.date.accessioned

2024-10-18T17:56:42Z

dc.date.available

2024-10-18T17:56:42Z

dc.date.issued

2024-09

dc.description.abstract

Alemtuzumab induction with belatacept/rapamycin-based maintenance immunotherapy (ABR) prevents kidney allograft rejection and specifically limits early costimulation blockade-resistant rejection (CoBRR). To evaluate the mechanisms by which this regimen alters CoBRR, we characterized the phenotype and functional response of preexisting memory cells to allogeneic endothelial cells using intracellular cytokine staining and flow cytometry. IL-7-induced lymphocyte proliferation in the presence or absence of rapamycin was assessed to characterize the phenotype of proliferating cells. Lymphocytes from 40 recipients who underwent transplant using the ABR regimen were studied longitudinally. The rapid immunoresponses of preexisting alloreactive cells to allogeneic endothelial cells were predominantly CD8+TNF-α+/IFN-γ+ cells. These cells were effector memory (TEM) and terminally differentiated effector memory cells lacking CD28 expression, and most were CD57+PD1-. Neither rapamycin nor belatacept directly inhibited these cells. IL-7, a cytokine induced during lymphopenia postdepletion, provoked dramatic CD8+ TEM cell proliferation and a low level of CD8+CD57+PD1- cell expansion in vitro. The IL-7 stimulation induced CD8+ cell mTOR phosphorylation, and rapamycin treatment markedly inhibited IL-7-induced TEM and CD57+PD1- cell expansion. This effect was evident in patients receiving the ABR in that the repopulation of CD8+CD57+PD1- TEM cells was substantially suppressed for at least 36 mo after transplant. These findings help define one mechanism by which a costimulation blockade/rapamycin-based therapy following alemtuzumab induction minimizes CoBRR, namely that in the presence of rapamycin, costimulation-resistant alloreactive cells are disproportionately ineffective at repopulating following post-transplant T cell depletion.

dc.identifier

267166

dc.identifier.issn

0022-1767

dc.identifier.issn

1550-6606

dc.identifier.uri

https://hdl.handle.net/10161/31576

dc.language

eng

dc.publisher

The American Association of Immunologists

dc.relation.ispartof

Journal of immunology (Baltimore, Md. : 1950)

dc.relation.isversionof

10.4049/jimmunol.2400146

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.title

Rapamycin Prevents Expansion of Costimulation Blockade-resistant CD8+ Alloreactive Memory Cells following Depletional Induction in Renal Transplant Recipients.

dc.type

Journal article

duke.contributor.orcid

Li, Shu|0009-0006-7190-2943

duke.contributor.orcid

Kirk, Allan D|0000-0003-2004-5962

pubs.begin-page

ji2400146

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Integrative Immunobiology

pubs.organisational-group

Pediatrics

pubs.organisational-group

Surgery

pubs.organisational-group

Surgery, Abdominal Transplant Surgery

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

University Initiatives & Academic Support Units

pubs.organisational-group

Initiatives

pubs.organisational-group

Duke Innovation & Entrepreneurship

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ji2400146.pdf
Size:
3.45 MB
Format:
Adobe Portable Document Format
Description:
Published version